1,2-diphosphahexaborane(4)2343 Tetrabromodiborane(4), B2Br4, forms a 1: 2 adduct 1 with PBr3, phosphane or 1,2-bis(dichlorophosphanyl)ethane to give B2C1, . which reacts at 350°C to closo-1,2-PzB4Br4 (4a) in 25% yield. P(SiMe& (2) and B2C14 . ClzPCHzCHzPClz (3), respectively.Compound 4a neither rearranges to the 1,6-isomer nor decom-Compound 2 represents the first phosphanediborane(4) poses to an appreciable extent upon heating to 650°C. B2C14 monoadduct with two boron atoms in different coordination reacts with equimolar amounts of either tris(trimethylsily1)-environment.
The 12-vertex closo-phosphaborane 1,7-P2B10Cl10 (1) has been prepared in low yield from the pyrolysis reaction of B2Cl4 with PCl3 at temperatures above 400 degrees C. A single-crystal X-ray structure determination of 1 (monoclinic space group P2(1)/n with a = 9.239(2) A, b = 16.786(3) A, c = 15.739(3) a, beta = 93.25(3) degrees, and Z = 4) confirmed that, consistent with its 26 skeletal electron count, the phosphaborane adopts a distorted icosahedral structure with the phosphorus atoms in the 1,7-positions. Crystals of 1 contain toluene in a 1:1 molar ratio embedded between each P atom of neighboring cluster molecules. Alteration of the pyrolytic conditions resulted in the formation of the phosphaboranes P4B8Cl6 (2) and P2B8Cl8 (3), which were characterized spectroscopically. Copyrolysis of B2Cl4 with a mixture of PCl3 and AsCl3 at 450 degrees C generated the six-vertex arsaphosphaborane AsPB4Cl4 (4) and traces of the icosahedral arsaphosphaborane AsPB10Cl10. These compounds are examples of heteroboranes which contain two different group-15 atoms within a single molecule.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.